Surgery
Volume 146, Issue 6 , Pages 1130-1137 , December 2009

Tertiary hyperparathyroidism: Is less than a subtotal resection ever appropriate? A study of long-term outcomes

,Accepted 24 September 2009.

References 

  1. Kerby J, Rue L, Blair H, Hudson S, Sellers M, Diethelm A. Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg. 1998;227:878–886
  2. Kilgo M, Pirsch J, Warner T, Starling J. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery. 1998;124:677–683discussion 83-4
  3. D'Alessandro AM, Melzer JS, Pirsch JD, Sollinger HW, Kalayoglu M, Vernon WB, et al. Tertiary hyperparathyroidism after renal transplantation: operative indications. Surgery. 1989;106:1049–1055discussion 55-6
  4. Nieto J, Ruiz-Cuevas P, Escuder A, Regas J, Callis L. Tertiary hyperparathyroidism after renal transplantation. Pediatr Nephrol. 1997;11:65–68
  5. Gilat H, Feinmesser R, Vinkler Y, Morgenstern S, Shvero J, Bachar G, et al. Clinical and operative management of persistent hyperparathyroidism after renal transplantation: a single-center experience. Head Neck. 2007;29:996–1001
  6. Nichol P, Starling J, Mack E, Klovning J, Becker B, Chen H. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg. 2002;235:673–678discussion 8-80
  7. Kebebew E, Duh Q, Clark O. Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. Arch Surg. 2004;139:974–977
  8. Triponez F, Dosseh D, Hazzan M, Noel C, Vanhille P, Proye C. Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg. 2005 Oct;92(10):1282–1287
  9. Triponez F, Kebebew E, Dosseh D, Duh Q, Hazzan M, Noel C, et al. Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery. 2006;140:990–997discussion 7-9
  10. Nichol P, Mack E, Bianco J, Hayman A, Starling J, Chen H. Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery. 2003;134:713–717discussion 7-9
  11. Haustein S, Mack E, Starling J, Chen H. The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery. 2005;138:1066–1071discussion 71
  12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  13. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  14. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl. 3):S1–201
  15. Gasparri G, Camandona M, Abbona G, Papotti M, Jeantet A, Radice E, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg. 2001;233:65–69
  16. Milas M, Weber C. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery. 2004;136:1252–1260
  17. Meier-Kriesche H, Steffen B, Hochberg A, Gordon R, Liebman M, Morris J, et al. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation. 2003;75:1341–1346

 Presented at the 30th Annual Meeting of the American Association of Endocrine Surgeons, Madison, Wisconsin, May 2–5, 2009.

 Supported in part by research grants from the American College of Surgeons Resident Research Scholarship and the National Institutes of Health (grant T32 CA009614-19 Physician Scientist Training in Cancer Medicine).

PII: S0039-6060(09)00567-4

doi: 10.1016/j.surg.2009.09.026

Surgery
Volume 146, Issue 6 , Pages 1130-1137 , December 2009